Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Analysis of the Paired TCR α- and β-chains of Single Human T Cells.
A practical guide to the treatment of neuromyelitis optica.
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
A palliative care hotline for multiple sclerosis: A pilot feasibility study.
FDA approves injectable drug to treat opioid-dependent patients
Optical coherence tomography in multiple sclerosis.
Segway use in individuals with multiple sclerosis.
Clinical assessment of noninvasive intracranial pressure absolute value measurement method.
Homophilic interaction of the L1 family of cell adhesion molecules.
About Tysabri
Prolongation of survival of rat cardiac allografts by T cell vaccination.
Tumefactive MS lesions under fingolimod: A case report and literature review.
The pill times 2: What every woman with multiple sclerosis should know.
Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Targeting IRF4 in autoimmune diseases.
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis.
[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa].
A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'
Discovery of peptoid ligands for anti-aquaporin 4 antibodies.
Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms.
Pages
« first
‹ previous
…
187
188
189
190
191
192
193
194
195
…
next ›
last »
